Baxter Stock Performance & 2025 Outlook: Earnings, Analyst Ratings, Price Target – News and Statistics
Jan 31, 2026
Baxter International Inc. (BAX), with a market capitalization of $10.1 billion, is a global healthcare company providing medical products and pharmaceuticals. According to a recent report on Barchart.com, the company’s stock has decreased 40.2% over the past 52 weeks, a period during which the broader S&P 500 Index ($SPX) gained 14.3%. However, on a year-to-date basis, BAX shares have risen 3.5%, outpacing the SPX’s 1.4% return.
Shares of the Deerfield, Illinois-based drug and medical device maker have also underperformed the State Street Health Care Select Sector SPDR ETF‘s (XLV) 4.2% increase over the same 52-week period.
On Oct. 30, despite reporting better-than-expected…
